Impact of admission hyperglycemia on short and long-term prognosis in acute myocardial infarction: MINOCA versus MIOCA.
Pasquale Paolisso, Alberto Foà, Luca Bergamaschi...
https://pubmed.ncbi.nlm.nih.gov/34560876/Actively Recruiting
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2026-01-30
11000
Participants Needed
3
Research Sites
208 weeks
Total Duration
Researchers are conducting an observational study called AMIPE to collect and analyze data on patients with acute coronary syndrome or myocardial injury. The study is both retrospective and prospective, enrolling patients admitted to participating hospitals from January 1, 2016, to December 31, 2023. The goal is to improve understanding and knowledge about these heart conditions by creating a detailed database of patient characteristics and outcomes. The study involves gathering information from patient medical records during hospitalization and requires written informed consent for prospective participants. No specific treatments are assigned as this is an observational study all diagnostic and therapeutic interventions follow established guidelines and good clinical practice. Researchers will document patient characteristics, long-term outcomes, and treatment regimens. Participants will be monitored for major outcomes such as all-cause mortality and major adverse cardiac events over 1, 3, and 5 years. Additional data on cardiovascular risk factors, clinical presentations, and complications will also be collected. Statistical analyses including univariate and multivariate methods will be used to evaluate these outcomes. The study is led by IRCCS Azienda Ospedaliero-Universitaria di Bologna and aims to provide new scientific evidence about these heart conditions.
CONDITIONS
Acute Myocardial Infarction: Prognostic and Therapeutic Evaluation
C
Carmine Pizzi, Prof
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - At admission and during hospital stay
Participants undergo diagnostic assessments related to acute coronary syndrome or myocardial injury, with data collected from in-hospital medical records.
1 to several visits depending on hospital stay
Duration - Up to 5 years
Participants are followed over time to document long-term outcomes, cardiovascular risk factors, and clinical presentations up to 5 years after initial diagnosis.
Periodic follow-up visits over 5 years
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Pasquale Paolisso, Alberto Foà, Luca Bergamaschi...
https://pubmed.ncbi.nlm.nih.gov/34560876/Marc P Bonaca, Stephen D Wiviott, Eugene Braunwald...
https://pubmed.ncbi.nlm.nih.gov/22199016/Lisa Canton, Damiano Fedele, Luca Bergamaschi...
https://pubmed.ncbi.nlm.nih.gov/37261384/Tomasz Baron, Kristina Hambraeus, Johan Sundström...
https://pubmed.ncbi.nlm.nih.gov/25331532/Yader Sandoval, Stephen W Smith, Anne Sexter...
https://pubmed.ncbi.nlm.nih.gov/28739197/Kristian Thygesen, Joseph S Alpert, Allan S Jaffe...
https://pubmed.ncbi.nlm.nih.gov/30571511/IRCCS Azienda Ospedaliero-Universitaria di Bologna
Lead Sponsor